Bovine Adenoviral Vector–based H5N1 Influenza Vaccine Overcomes Exceptionally High Levels of Pre-existing Immunity Against Human Adenovirus
Open Access
- 1 May 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (5) , 965-971
- https://doi.org/10.1038/mt.2008.12
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoproteinVaccine, 2007
- Effect of Preexisting Immunity to Adenovirus Human Serotype 5 Antigens on the Immune Responses of Nonhuman Primates to Vaccine Regimens Based on Human- or Chimpanzee-Derived Adenovirus VectorsJournal of Virology, 2007
- Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protectionVirology, 2007
- Avian Influenza Virus (H5N1): a Threat to Human HealthClinical Microbiology Reviews, 2007
- Structure-Based Identification of a Major Neutralizing Site in an Adenovirus HexonJournal of Virology, 2007
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006
- Age Dependence of Adenovirus-Specific Neutralizing Antibody Titers in Individuals from Sub-Saharan AfricaJournal of Clinical Microbiology, 2006
- Bovine adenovirus type 3 internalization is independent of primary receptors of human adenovirus type 5 and porcine adenovirus type 3Biochemical and Biophysical Research Communications, 2005
- Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in cultureBiochemical and Biophysical Research Communications, 2004
- Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccineVirus Research, 2004